Seoul [South Korea], December 31 (ANI/Global Economic): Samsung Electronics announced on the 30th that sales of its foldable phone Galaxy Z series increased more than four times this year from last year.
Seoul [South Korea], December 31 (ANI/Global Economic): K-pop group BLACKPINK member Lisa's first solo album song 'MONEY' has set a new record on Spotify, the world's largest music streaming platform.
Seoul [South Korea], December 30 (ANI/Global Economic): South Korea's childbirths in October hit a record low. The population naturally declined for 24 consecutive months, as the number of newborn babies decreased and the number of death increased. The cumulative declined population reached
Seoul [South Korea], December 30 (ANI/Global Economic): Seegene, a Korean molecular diagnostic company, announced on the 29th that it will export 1.7 million doses of COVID-19 test reagent to Israel.
Seoul [South Korea], December 29 (ANI/Global Economic): Hyundai Engineering announced on the 28th that it has completed construction of GTL (Gas-to-Liquid) plant worth $2.62 billion (about 3.1 trillion won) in Uzbekistan.
Seoul [South Korea], December 29 (ANI/Global Economic): As prices of raw materials for battery cells have recently increased, Korean battery manufacturers have entered the waste battery market. This is because core materials of the battery, such as nickel and cobalt, can be extracted from th
Seoul [South Korea], December 29 (ANI/Global Economic): As SK Bioscience announced its plan to open a new R&PD center in Songdo, Incheon, three Korean bio companies called 'Big 3,' including Celltrion, Samsung Biologics, and SK Bioscience, are expected to gather in Songdo Bio-cluster.
Seoul [South Korea], December 28 (ANI/Global Economic): 'Paxlovid,' the COVID-19 oral treatment developed by a global pharmaceutical company Pfizer, received emergency use authorization from the Ministry of Food and Drug Safety (MFDS) on the 27th. It is expected to be used from the end of Ja
Seoul [South Korea], December 24 (ANI/Global Economic): The Korean government will invest 545.7 billion in the development of COVID-19 treatments and vaccines next year.